160 related articles for article (PubMed ID: 27700540)
1. A SDHC Founder Mutation Causes Paragangliomas (PGLs) in the French Canadians: New Insights on the SDHC-Related PGL.
Bourdeau I; Grunenwald S; Burnichon N; Khalifa E; Dumas N; Binet MC; Nolet S; Gimenez-Roqueplo AP
J Clin Endocrinol Metab; 2016 Dec; 101(12):4710-4718. PubMed ID: 27700540
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic variability and risk of malignancy in SDHC-linked paragangliomas: lessons from three unrelated cases with an identical germline mutation (p.Arg133*).
Bickmann JK; Sollfrank S; Schad A; Musholt TJ; Springer E; Miederer M; Bartsch O; Papaspyrou K; Koutsimpelas D; Mann WJ; Weber MM; Lackner KJ; Rossmann H; Fottner C
J Clin Endocrinol Metab; 2014 Mar; 99(3):E489-96. PubMed ID: 24423348
[TBL] [Abstract][Full Text] [Related]
3. SDHB, SDHC, and SDHD mutation screen in sporadic and familial head and neck paragangliomas.
Mhatre AN; Li Y; Feng L; Gasperin A; Lalwani AK
Clin Genet; 2004 Nov; 66(5):461-6. PubMed ID: 15479192
[TBL] [Abstract][Full Text] [Related]
4. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.
Schiavi F; Boedeker CC; Bausch B; Peçzkowska M; Gomez CF; Strassburg T; Pawlu C; Buchta M; Salzmann M; Hoffmann MM; Berlis A; Brink I; Cybulla M; Muresan M; Walter MA; Forrer F; Välimäki M; Kawecki A; Szutkowski Z; Schipper J; Walz MK; Pigny P; Bauters C; Willet-Brozick JE; Baysal BE; Januszewicz A; Eng C; Opocher G; Neumann HP;
JAMA; 2005 Oct; 294(16):2057-63. PubMed ID: 16249420
[TBL] [Abstract][Full Text] [Related]
5. Genetic and clinical characteristics of head and neck paragangliomas in a Chinese population.
Zheng X; Wei S; Yu Y; Xia T; Zhao J; Gao S; Li Y; Gao M
Laryngoscope; 2012 Aug; 122(8):1761-6. PubMed ID: 22566157
[TBL] [Abstract][Full Text] [Related]
6. Malignant head and neck paragangliomas in SDHB mutation carriers.
Boedeker CC; Neumann HP; Maier W; Bausch B; Schipper J; Ridder GJ
Otolaryngol Head Neck Surg; 2007 Jul; 137(1):126-9. PubMed ID: 17599579
[TBL] [Abstract][Full Text] [Related]
7. Genetics and the clinical approach to paragangliomas.
Schulte KM; Talat N; Galata G; Aylwin S; Izatt L; Eisenhofer G; Barthel A; Bornstein SR
Horm Metab Res; 2014 Dec; 46(13):964-73. PubMed ID: 25014332
[TBL] [Abstract][Full Text] [Related]
8. High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations.
Lima J; Feijão T; Ferreira da Silva A; Pereira-Castro I; Fernandez-Ballester G; Máximo V; Herrero A; Serrano L; Sobrinho-Simões M; Garcia-Rostan G
J Clin Endocrinol Metab; 2007 Dec; 92(12):4853-64. PubMed ID: 17848412
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
[TBL] [Abstract][Full Text] [Related]
10. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
Neumann HP; Pawlu C; Peczkowska M; Bausch B; McWhinney SR; Muresan M; Buchta M; Franke G; Klisch J; Bley TA; Hoegerle S; Boedeker CC; Opocher G; Schipper J; Januszewicz A; Eng C;
JAMA; 2004 Aug; 292(8):943-51. PubMed ID: 15328326
[TBL] [Abstract][Full Text] [Related]
11. Mutations associated with succinate dehydrogenase D-related malignant paragangliomas.
Timmers HJ; Pacak K; Bertherat J; Lenders JW; Duet M; Eisenhofer G; Stratakis CA; Niccoli-Sire P; Tran BH; Burnichon N; Gimenez-Roqueplo AP
Clin Endocrinol (Oxf); 2008 Apr; 68(4):561-6. PubMed ID: 17973943
[TBL] [Abstract][Full Text] [Related]
12. SDHC Promoter Methylation, a Novel Pathogenic Mechanism in Parasympathetic Paragangliomas.
Bernardo-Castiñeira C; Valdés N; Sierra MI; Sáenz-de-Santa-María I; Bayón GF; Perez RF; Fernández AF; Fraga MF; Astudillo A; Menéndez R; Fernández B; Del Olmo M; Suarez C; Chiara MD
J Clin Endocrinol Metab; 2018 Jan; 103(1):295-305. PubMed ID: 29126304
[TBL] [Abstract][Full Text] [Related]
13. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER
Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914
[TBL] [Abstract][Full Text] [Related]
14. The clinical phenotype of SDHC-associated hereditary paraganglioma syndrome (PGL3).
Else T; Marvin ML; Everett JN; Gruber SB; Arts HA; Stoffel EM; Auchus RJ; Raymond VM
J Clin Endocrinol Metab; 2014 Aug; 99(8):E1482-6. PubMed ID: 24758179
[TBL] [Abstract][Full Text] [Related]
15. A novel mutation in the SDHD gene responsible for familial paraganglioma. Medical and psychological implications.
Prontera P; Ferrando B; Giuliani V; Falcinelli F; Mencarelli A; Rogaia D; Pasini B; Donti E
Genet Couns; 2008; 19(4):413-8. PubMed ID: 19239085
[TBL] [Abstract][Full Text] [Related]
16. Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients.
Currás-Freixes M; Inglada-Pérez L; Mancikova V; Montero-Conde C; Letón R; Comino-Méndez I; Apellániz-Ruiz M; Sánchez-Barroso L; Aguirre Sánchez-Covisa M; Alcázar V; Aller J; Álvarez-Escolá C; Andía-Melero VM; Azriel-Mira S; Calatayud-Gutiérrez M; Díaz JÁ; Díez-Hernández A; Lamas-Oliveira C; Marazuela M; Matias-Guiu X; Meoro-Avilés A; Patiño-García A; Pedrinaci S; Riesco-Eizaguirre G; Sábado-Álvarez C; Sáez-Villaverde R; Sainz de Los Terreros A; Sanz Guadarrama Ó; Sastre-Marcos J; Scolá-Yurrita B; Segura-Huerta Á; Serrano-Corredor Mde L; Villar-Vicente MR; Rodríguez-Antona C; Korpershoek E; Cascón A; Robledo M
J Med Genet; 2015 Oct; 52(10):647-56. PubMed ID: 26269449
[TBL] [Abstract][Full Text] [Related]
17. Head and neck paragangliomas: Report of 175 patients (1989-2010).
Papaspyrou K; Mewes T; Rossmann H; Fottner C; Schneider-Raetzke B; Bartsch O; Schreckenberger M; Lackner KJ; Amedee RG; Mann WJ
Head Neck; 2012 May; 34(5):632-7. PubMed ID: 21692132
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal changes in sporadic and familial head and neck paragangliomas.
Sevilla MA; Hermsen MA; Weiss MM; Grimbergen A; Balbín M; Llorente JL; Rodrigo JP; Suárez C
Otolaryngol Head Neck Surg; 2009 May; 140(5):724-9. PubMed ID: 19393419
[TBL] [Abstract][Full Text] [Related]
19. SDHC mutations in hereditary paraganglioma/pheochromocytoma.
Müller U; Troidl C; Niemann S
Fam Cancer; 2005; 4(1):9-12. PubMed ID: 15883704
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and spectrum of SDHx mutations in pheochromocytoma and paraganglioma in patients from Belgium: an update.
Persu A; Lannoy N; Maiter D; Mendola A; Montigny P; Oriot P; Vinck W; Garin P; Hamoir M; Vikkula M
Horm Metab Res; 2012 May; 44(5):349-53. PubMed ID: 22566194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]